Pharma

- Advertisement -
Ad imageAd image
Hitachi and Shionogi deploy genAI in drug regulatory work

Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd. to roll out a generative AI solution that supports the creation of regulatory documents in drug development. The…

PHC secures exclusive rights to MaxCyte ExPERT in Japan

The Biomedical Division of PHC Corporation, a subsidiary of PHC Holdings Corporation…

PRD Therapeutics Begins First Human Trial for PRD001

 PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is…

Axcelead, A2 Healthcare Unite for Pharma R\&D in Japan

Axcelead, Inc., A2 Healthcare Corporation and another company have formed a partnership.…

Fujirebio Acquires PSG to Boost Biological Material Supply

H.U. Group Holdings Inc., through its wholly owned subsidiary Fujirebio Holdings, Inc.…

NEC With Chugai Use AI to Speed Cancer Drug Predictions

NEC Corporation and Chugai Pharmaceutical Co., Ltd. worked together on an AI…

HekaBio And Alfresa Form Strategic Biopharma Partnership

HekaBio K.K. is a biopharma and MedTech platform in Japan. It has…

Infocom Unveils DigiPro EPPV for Early Drug Monitoring

Infocom Corporation is pleased to announce that it has begun offering "DigiPro…

Agilent debuts next-gen InfinityLab Pro iQ LC/MS systems

Agilent Technologies Inc. is pleased to announce the launch of the Agilent…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community